HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER

被引：3
|
作者：
BICHEL, P
JAKOBSEN, A
ORNTOFT, TF
机构：
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, INST PATHOL, DEPT CLIN CHEM, DK-8000 AARHUS, DENMARK
[2] VEJLE CENT HOSP, INST PATHOL, AARHUS, DENMARK
[3] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, AARHUS, DENMARK
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 1991年 / 1卷 / 05期
关键词：
CA-125; HISTOCHEMICAL DISTRIBUTION; OVARY CARCINOMA; PROGNOSIS;
D O I：
10.1111/j.1525-1438.1991.tb00040.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The study comprises 66 patients with stage Ill and IV serous ovarian carcinoma While the percentage of CA-125 positive cells and the staining intensity showed no correlation to patient survival, the pattern of CA-125 distribution, membranous versus cytoplasmic, was significantly correlated to survival. In accordance with other observations on switching of the antigen reaction f rom membrane to cytoplasm with increasing grade of atypia or malignancy, patients with membrane positive CA-125 tumors had a significantly better prognosis than did patients with CA-125 in the cytoplasm. Furthermore, there was excellent agreement between, on the one hand, the binding pattern of CA-125 and, on the other, the ploidy of the tumor cells and the HGI histopathologic grading index, both previously shown to be of prognostic significance.
引用
收藏
页码：199 / 204
页数：6
相关论文
共 50 条
  • [41] IS CA-125 ACTUALLY A TUMOR-MARKER FOR OVARIAN-CANCER
    COLLAZOS, J
    ACTA ONCOLOGICA, 1995, 34 (02) : 268 - 268
  • [42] EVALUATION OF SERUM CA-125 LEVELS IN THE MONITORING OF OVARIAN-CANCER
    VERGOTE, IB
    BORMER, OP
    ABELER, VM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (01) : 88 - 92
  • [43] PROGNOSTIC-SIGNIFICANCE OF CA-125 HALF-LIFE FOR THE FURTHER OUTCOME OF PATIENTS WITH ADVANCED OVARIAN-CANCER
    MEIER, W
    STIEBER, P
    FATEHMOGHADAM, A
    EIERMANN, W
    HEPP, H
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1992, 52 (09) : 526 - 532
  • [44] A CA125 SCORE AS A PROGNOSTIC INDEX IN PATIENTS WITH OVARIAN-CANCER
    ROSEN, A
    SEVELDA, P
    KLEIN, M
    SPONA, J
    BECK, A
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1990, 247 (03) : 125 - 129
  • [45] PREOPERATIVE EVALUATION OF SERUM CA-125 LEVELS IN PATIENTS WITH PRIMARY EPITHELIAL OVARIAN-CANCER
    EINHORN, N
    BAST, RC
    KNAPP, RC
    TJERNBERG, B
    ZURAWSKI, VR
    OBSTETRICS AND GYNECOLOGY, 1986, 67 (03): : 414 - 416
  • [46] CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer
    Chen, Xiaoxiang
    Zhang, Jing
    Cheng, Wenjun
    Chang, Doo Young
    Huang, Jianfei
    Wang, Xuan
    Jia, Lizhou
    Rosen, Daniel G.
    Zhang, Wei
    Yang, Da
    Gershenson, David M.
    Sood, Anil K.
    Bast, Robert C., Jr.
    Liu, Jinsong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (05) : 815 - 822
  • [47] CA-125 IN SERUM DURING TREATMENT AND FOLLOW-UP OF OVARIAN-CANCER PATIENTS
    BORMER, O
    VERGOTE, I
    TUMOUR BIOLOGY, 1986, 7 (04): : 282 - 282
  • [48] SERUM TETRANECTIN AND CA-125 USED TO MONITOR THE COURSE OF TREATMENT IN OVARIAN-CANCER PATIENTS
    HOGDALL, CK
    HORDING, U
    NORGAARDPEDERSEN, B
    TOFTAGERLARSEN, K
    CLEMMENSEN, I
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1994, 57 (03): : 175 - 178
  • [49] CA-125, TPA AND CEA, A USEFUL MARKER COMBINATION IN OVARIAN-CANCER
    THOLANDER, B
    TAMSEN, L
    SJOBERG, O
    KIVIRANTA, A
    STENDAHL, U
    HALLMAN, K
    TUMOUR BIOLOGY, 1986, 7 (04): : 316 - 316
  • [50] The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer
    Deng, XH
    Hogdall, EVS
    Hogdall, CK
    Norgaard-Pedersen, B
    Jorgensen, M
    Nielsen, H
    Engelholm, SAA
    GYNECOLOGIC ONCOLOGY, 2000, 79 (03) : 416 - 419
12345